American Portfolios Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-50
| Closed | -$9.19K | – | 3569 |
|
|
2021
Q2 | $9.19K | Sell |
50
-1,405
| -97% | -$258K | ﹤0.01% | 2563 |
|
|
2021
Q1 | $222K | Buy |
1,455
+396
| +37% | +$60.6K | 0.01% | 972 |
|
|
2020
Q4 | $165K | Sell |
1,059
-70
| -6% | -$10.9K | 0.01% | 961 |
|
|
2020
Q3 | $129K | Buy |
1,129
+155
| +16% | +$17.7K | 0.01% | 973 |
|
|
2020
Q2 | $109K | Buy |
974
+305
| +46% | +$34.2K | 0.01% | 965 |
|
|
2020
Q1 | $60.1K | Buy |
669
+209
| +45% | +$18.8K | 0.01% | 1091 |
|
|
2019
Q4 | $49.7K | Buy |
460
+140
| +44% | +$15.1K | ﹤0.01% | 1347 |
|
|
2019
Q3 | $31.3K | Sell |
320
-71
| -18% | -$6.95K | ﹤0.01% | 1481 |
|
|
2019
Q2 | $51.2K | Buy |
391
+6
| +2% | +$786 | ﹤0.01% | 1263 |
|
|
2019
Q1 | $52K | Sell |
385
-2
| -0.5% | -$270 | ﹤0.01% | 1177 |
|
|
2018
Q4 | $37.7K | Buy |
387
+17
| +5% | +$1.66K | ﹤0.01% | 1129 |
|
|
2018
Q3 | $51.4K | Buy |
370
+30
| +9% | +$4.17K | 0.01% | 1096 |
|
|
2018
Q2 | $42.2K | Hold |
340
| – | – | 0.01% | 1143 |
|
|
2018
Q1 | $37.9K | Buy |
340
+30
| +10% | +$3.34K | 0.01% | 1141 |
|
|
2017
Q4 | $37.1K | Buy |
+310
| New | +$37.1K | 0.01% | 1111 |
|